HNGE Hinge Health, Inc. — earnings, filings & institutional moves

Price chart

Daily historical data with per-account defaults

Latest close

$63.62

Period return

+14.57 (+29.70%)

Volume

2.4M

2026-06-05O $63 H $66.55 L $63 C $63.62MA5 $60.93MA20 $56.28MA60 $47.18MA120 $45.04

6M · 124 barsYahoo Finance · USD2025-12-08 → 2026-06-05

Recent event timeline

Filings, earnings, research, and institutional changes — newest first

View all →

2026. 05. 07.LowBUYlast month
Canaccord Genuity: Buy
US analyst rating / recommendation change.
2026. 05. 07.LowBUYlast month
Stifel: Buy
US analyst rating / recommendation change.
2026. 05. 07.LowBUYlast month
RBC Capital: Outperform
US analyst rating / recommendation change.

Recent earnings

Consensus vs. actual, and revenue trend

Earnings tab →

Research actions

Consensus PT $70.73 · 15 analysts

Research tab →

AI Brief (Premium)

Automated summary from public sources · not investment advice

Brief tab →

No AI brief generated yet. You can create one from the Brief tab.

Top institutions (13F)

Ranked by position value

Institutions tab →

Company info

Hinge Health, Inc. focuses on building a health system that scales and automates the delivery of care using technology. It designs its platform to address musculoskeletal system care (MSK), including acute injury, chronic pain, and post-surgical rehabilitation. The company also provides personalized and automated MSK care through AI-powered motion tracking technology and a proprietary electrical nerve stimulation wearable device. It primarily serves self-insured employers. The company was founded in 2012 and is headquartered in San Francisco, California.

Sector: Healthcare
Industry: Health Information Services
HQ: San Francisco, CA, United States
Fiscal year end: —
Employees: 1,437
IPO date: —

View details →